COVID-19 Resources

Camp Kudzu relies on scientific evidence-based information for recommendations on responding to diabetes and coronavirus. Here are links to reliable resources providing information based on the current knowledge of COVID-19.

• World Health Organization
• Center for Disease Control and Prevention
• American Diabetes Association

Camp Kudzu has reached out to all three insulin manufacturers – Lilly, Novo Nordisk, and Sanofi, in regards to insulin supply. All three manufacturers have reported no shortage or impact to access during the COVID-19 crisis at this time. A number of resources have been made available to help people with diabetes during this unprecedented time. We will update the list below as new resources are made known.

• Information on health insurance providers’ response to COVID-19. Many providers have removed copays and out-of-pocket costs on testing for COVID-19 and/or have waived or reduced costs for treatment. Additionally, some providers are making telehealth benefits available.
• The Diabetes Disaster Response Coalition (DDRC) has information on emergency prescription refills and regulations by state.
• CVS waives home delivery fees for prescription medications. You can also add additional items to be delivered such as vitamins and OTC medications.
• Sanofi offers its Insulins Valyou Savings Program for those who are uninsured. Eligible patients will pay $99 for up to 10 vials or packs of pre-filled pens for the duration of the program. Those needing additional assistance can apply for the Sanofi Patient Assistance Connection program. Additionally, Sanofi offers savings for patients with commercial or private insurance.
• Eli Lilly offers $35 co-pay through the Lilly Insulin Value Program in response to the COVID-19 crisis. This covers most Lilly insulins including all Humalog formulations. Lilly also offers the Lilly Cares program that provides free Lilly medications for patients who meet program eligibility requirements.
• Novo Nordisk offers a 90-day insulin supply to those experiencing financial hardship due to COVID-19. Please check eligibility requirements for enrollment in the Novo Nordisk Diabetes Patient Assistance Program (PAP) before applying.
• Walmart offers Novolin ReliOn insulin for $25 without a prescription or insurance. It is offered in both regular human (“R” – for use at mealtime) and NPH (“N” – a longer-acting basal insulin). ** Note that NPN and regular insulins work differently so be sure to discuss your decision with a healthcare professional before changing to one of these insulins.
• CVS offers Novolin for $25 through the Reduced Rx program.
• Insulet, the maker of Omnipod, offers an expansion to its financial assistance program to current customers who have been impacted by COVID-19. Upon meeting certain financial criteria, a current customer may receive up to a six-month supply of products (60 Pods) free of charge.
• Xeris Pharmaceuticals offers $0 co-pay for GVOKE PFS glucagon for those with diabetes. Offer is effective through April 30, 2020.
• If you are in need of a community health clinic or pharmacy in your area that may offer free or low-cost services and medications you can try the National Association of Free & Charitable Clinics (NAFC).